Laura A. Lane
Corporate Officer/Principal at ELI LILLY AND COMPANY
Laura A. Lane active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2022-07-31 | - |
Career history of Laura A. Lane
Former positions of Laura A. Lane
| Companies | Position | Start | End |
|---|---|---|---|
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private Equity Analyst | 2019-02-28 | 2021-09-30 |
| Private Equity Investor | 2021-09-30 | 2022-07-31 | |
Virion Biotherapeutics Ltd.
 Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Chief Operating Officer | 2015-02-28 | 2018-06-29 |
| Founder | 2015-02-28 | 2018-06-29 |
Training of Laura A. Lane
| University of Cambridge | Doctorate Degree |
Statistics
International
| United Kingdom | 4 |
| United States | 2 |
Operational
| Private Equity Analyst | 1 |
| Private Equity Investor | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 2 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Virion Biotherapeutics Ltd.
Virion Biotherapeutics Ltd. BiotechnologyHealth Technology Virion Biotherapeutics Ltd. operates as a biotechnology company that develops novel therapeutics for respiratory viral infections. The firm focuses on prevention and treatment of influenza and respiratory syncytial virus. The company was founded by Nigel Dimmock and Andrew Easton in 2017 and is headquartered in Coventry, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Laura A. Lane
- Experience
